Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 42,660 shares at $87.05 ($3.7M) on 2024-03-04, disclosed to the SEC on 2024-03-04.
Scheduled sale ($3.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.21 | 13,310 | $1.1M | 31.1% |
| 2 | $86.21 | 13,310 | $1.1M | 31.1% |
| 3 | $87.05 | 16,040 | $1.4M | 37.8% |
| Total | $86.53 avg | 42,660 | $3.7M | 100% |
| Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |
| EW | SELL | 2023-12-13 | $3.6M | — | Filing → |